APM News and Press, Aptorum Group Limited From 04/28/23

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “We”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced financ...

(All amounts are in Canadian dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - April 14, 2023) - Andean Precious Metals Corp. (TSXV: APM) (OTCQX: ANPMF) ("Andean" or the "Company") announced that on April 14, 2023, it granted restricted share units ("RSUs") and stock options ...

2023-03-27 07:41:08 ET Aptorum Group ( NASDAQ: APM ) signed a non-binding letter of intent to acquire 100% of URF Holding Group Limited and its underlying businesses by the further issuance of the company's class A ordinary shares as consideration. U Group's busin...

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Company”), today announced that it entered into a non-binding Letter of Intent and Term Sheet (“Term Sheet”) for the acquisition (“Transaction”...

ORLANDO, FL / ACCESSWIRE / March 17, 2023 / RedChip Companies will air new interviews with Aptorum Group Limited (Nasdaq:APM, Euronext Paris:APM) and ASP Isotopes Inc. (Nasdaq:ASPI) on The RedChip Money Report® on Bloomberg TV, this Saturday, March 18, at 7 p.m. Eastern Time (ET). Bloomberg...

2023 guidance for production and AISC per ounce Toronto, Ontario--(Newsfile Corp. - March 16, 2023) - Andean Precious Metals Corp.  (TSXV: APM) (OTCQX: ANPMF) ( "Andean" or the "Company" ) reported its operating and financial results for the three and twelve-month periods ended December ...

Toronto, Ontario--(Newsfile Corp. - March 10, 2023) - Andean Precious Metals Corp. (TSXV: APM) (OTCQX: ANPMF) (" Andean " or the " Company ") is expected to report its financial and operating results for the fourth quarter and year ended December 31, 2022 on Thursday, March 16, 2023, after market...

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces the completion of the Pre-IND discussions with the US Food and Drug Administration (“US FDA”...

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces the completion of an end of Phase 1 (EOP1) meeting with the US Food and Drug Administration (“US F...

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group”), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to tackling unmet medical needs, announces the exciting commercial launch of NativusWell &#x...